Solid Biosciences (SLDB) Share-based Compensation (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | Solid Biosciences | 713.77 Mn | 333.09 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.74% |
| Dec 31, 2025 | 65.48% |
| Sep 30, 2025 | 24.90% |
| Jun 30, 2025 | -5.87% |
| Mar 31, 2025 | -12.56% |
| Dec 31, 2024 | 27.58% |
| Sep 30, 2024 | 43.16% |
| Jun 30, 2024 | 29.86% |
| Mar 31, 2024 | -16.87% |
| Dec 31, 2023 | 19.26% |
| Sep 30, 2023 | -16.41% |
| Jun 30, 2023 | -8.22% |
| Mar 31, 2023 | 33.46% |
| Dec 31, 2022 | 4.13% |
| Sep 30, 2022 | -15.99% |
| Jun 30, 2022 | -30.55% |
| Mar 31, 2022 | -23.51% |
| Dec 31, 2021 | -0.03% |
| Sep 30, 2021 | -6.02% |
| Jun 30, 2021 | 25.04% |
| Mar 31, 2021 | 15.45% |
| Dec 31, 2020 | -8.90% |
| Sep 30, 2020 | -14.77% |
| Jun 30, 2020 | 4.48% |
| Mar 31, 2020 | -8.81% |
| Dec 31, 2019 | 0.35% |
| Sep 30, 2019 | -13.27% |
| Jun 30, 2019 | 11.74% |
| Mar 31, 2019 | 72.41% |
| Dec 31, 2018 | 12.97% |
| Sep 30, 2018 | 37.28% |
| Jun 30, 2018 | 59.83% |
| Mar 31, 2018 | -0.49% |
| Dec 31, 2017 | 4.18% |
| Sep 30, 2017 | 62.22% |
| Jun 30, 2017 | -84.92% |